drugset / Trial / NCT00141310

Sildenafil Citrate for the Treatment of Established Pre-Eclampsia

NCT00141310

Phase 2 Terminated 76 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia

Timeline

Start
2004-09
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 80 mg Oral

Indications